News & Articles

Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations

Explore topics from Alzheimer's disease and mRNA vaccine production to SARS-CoV-2 detection in wastewater and nanoplastic characterization

The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality

It is hoped the project will lead to improved quality of life for patients

Top talks presenting the latest technologies, research and applications are now available on demand

Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative

Dr. Samuel Dominguez shares the importance of robust testing methods and diagnostic stewardship

Explore topics from NGS and disinfectants in the food and beverage industry to high-resolution ion mobility mass spectrometry, and CAR-T cell sensitivity and persistence

Novel chip-based diagnostic technology can detect individual viral antigens in nasal swab samples to identify the viruses that cause COVID-19 and flu with a single test

Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India

Guest editorial: Learn how clinicians can utilize diagnostic information to make decisions when examining suspected SARS-CoV-2 patients

The new Access AMH Advanced aims to provide validated cut-offs for the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilization (IVF)

Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more

Catch up on topics from A-TEEM spectroscopy and DNA sequencing to advances in in vitro diagnostics, advancing nano-material research with wet-chemical synthesis and biopharmaceutical R&D

Collaboration follows successful acquisition and commercialization of Oxsed, an Oxford University Spin-out, to scale OxLAMP rapid COVID-19 test globally

Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%

The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples

New findings pave way to potentially improved assessment of measurable residual disease in AML patients